MCK McKesson Corporation
Stock · NYSE · United States · Healthcare · US58155Q1031
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by McKesson Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
1,060.84 USD
-1.04%
52-week range
723.68 – 1,121.50
Dividend yield0.35%
Market cap122.5B
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:42. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 07 Apr 2022 | 311.09 | 321.66 | 310.57 | 320.14 | +2.75% | 1,395,500 | |
| 06 Apr 2022 | 307.16 | 313.24 | 307.05 | 311.57 | +1.49% | 951,300 | |
| 05 Apr 2022 | 304.87 | 311.74 | 304.87 | 307.00 | +0.41% | 1,254,300 | |
| 04 Apr 2022 | 305.44 | 307.00 | 302.22 | 305.76 | -0.40% | 1,523,600 | |
| 01 Apr 2022 | 306.36 | 308.61 | 305.59 | 307.00 | +0.28% | 854,300 | |
| 31 Mar 2022 | 306.14 | 309.20 | 305.31 | 306.13 | -0.29% | 1,247,900 | |
| 30 Mar 2022 | 307.64 | 309.07 | 304.78 | 307.02 | +0.01% | 1,236,700 | |
| 29 Mar 2022 | 308.27 | 309.02 | 303.19 | 307.00 | -0.48% | 1,048,100 | |
| 28 Mar 2022 | 308.83 | 309.48 | 306.21 | 308.49 | -0.64% | 1,150,300 | |
| 25 Mar 2022 | 305.00 | 310.48 | 304.21 | 310.48 | +2.15% | 1,145,200 | |
| 24 Mar 2022 | 299.47 | 303.99 | 299.47 | 303.95 | +1.31% | 1,892,100 | |
| 23 Mar 2022 | 299.92 | 303.05 | 298.49 | 300.02 | +0.03% | 1,093,600 | |
| 22 Mar 2022 | 302.56 | 303.99 | 299.06 | 299.92 | -0.01% | 1,615,200 | |
| 21 Mar 2022 | 299.05 | 305.71 | 298.42 | 299.94 | +0.30% | 1,389,100 | |
| 18 Mar 2022 | 297.60 | 299.63 | 292.40 | 299.05 | +1.40% | 3,132,500 | |
| 17 Mar 2022 | 290.83 | 295.21 | 289.95 | 294.92 | +1.22% | 2,107,600 | |
| 16 Mar 2022 | 291.19 | 293.40 | 287.14 | 291.36 | +0.25% | 1,217,000 | |
| 15 Mar 2022 | 285.00 | 291.42 | 283.88 | 290.63 | +2.03% | 1,364,100 | |
| 14 Mar 2022 | 282.81 | 285.00 | 279.31 | 284.85 | +1.29% | 1,265,400 | |
| 11 Mar 2022 | 280.15 | 284.28 | 278.77 | 281.23 | +0.40% | 1,018,900 | |
| 10 Mar 2022 | 273.99 | 281.36 | 273.08 | 280.12 | +1.30% | 1,172,400 | |
| 09 Mar 2022 | 276.17 | 279.11 | 273.04 | 276.53 | +1.39% | 950,200 | |
| 08 Mar 2022 | 277.26 | 279.62 | 271.12 | 272.75 | -2.04% | 1,565,900 | |
| 07 Mar 2022 | 279.59 | 283.66 | 276.53 | 278.42 | -1.21% | 1,943,000 | |
| 04 Mar 2022 | 273.89 | 282.34 | 273.51 | 281.82 | +0.59% | 1,387,600 |
Page 47 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- McKesson (MCK) Plans Medical Surgical Spin Off With $1.25 Billion Backing (opens in a new tab) Simply Wall St. · 08 Nov 2026 08:12
- McKesson Q2 Earnings Call Highlights (opens in a new tab) MarketBeat · 07 Nov 2026 16:14
- Is McKesson Stock Increasing Your Market Risk? (opens in a new tab) Trefis · 06 Nov 2026 23:26
- McKesson (MCK) Upgraded to Buy: Here's What You Should Know (opens in a new tab) Zacks · 06 Nov 2026 16:00
- McKesson Corporation (MCK) Hit a 52 Week High, Can the Run Continue? (opens in a new tab) Zacks · 06 Nov 2026 13:15
- Drug Wholesalers Go Three-For-Three In Earnings Beats, But Only Two Stocks Pop (opens in a new tab) Investor's Business Daily · 05 Nov 2026 21:24
- The Biggest Drug Wholesaler Just Crushed Earnings Views — Here's What To Know (opens in a new tab) Investor's Business Daily · 05 Nov 2026 21:17
- UBS Maintains Buy on McKesson, Raises Price Target to $1250 (opens in a new tab) Benzinga · 05 Nov 2026 20:58
- McKesson Corp.: Normalized Earnings Suggest Attractive Valuation (opens in a new tab) SeekingAlpha · 05 Nov 2026 18:50
- MCK Q2 Earnings Call Highlights Raised Outlook and Specialty Growth (opens in a new tab) Zacks · 05 Nov 2026 17:27
- TD Cowen Maintains Buy on McKesson, Raises Price Target to $1200 (opens in a new tab) Benzinga · 05 Nov 2026 16:31
- Leerink Partners Maintains Outperform on McKesson, Raises Price Target to $1200 (opens in a new tab) Benzinga · 05 Nov 2026 15:53
- RBC Capital Maintains Sector Perform on McKesson, Raises Price Target to $965 (opens in a new tab) Benzinga · 05 Nov 2026 15:36
- McKesson Corporation Q2 2027 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 13:30
- MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised (opens in a new tab) Zacks · 05 Nov 2026 13:00
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 1,072.00 USD
- Market cap
- 122.5B
- Dividend yield
- 0.35%
- 5-year average yield
- 0.46%
- Payout ratio
- 9%
- Last dividend
- 0.9400 USD · 01 Dec 2026
- Next ex-dividend date
- 01 Dec 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Distribution
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 01 Sep 2026 | 0.9400 USD |
| 01 Jun 2026 | 0.8200 USD |
| 02 Mar 2026 | 0.8200 USD |
| 01 Dec 2025 | 0.8200 USD |
| 02 Sep 2025 | 0.8200 USD |
| 02 Jun 2025 | 0.7100 USD |
| 03 Mar 2025 | 0.7100 USD |
| 02 Dec 2024 | 0.7100 USD |
| 30 Aug 2024 | 0.7100 USD |
| 03 Jun 2024 | 0.6200 USD |
| 29 Feb 2024 | 0.6200 USD |
| 30 Nov 2023 | 0.6200 USD |
Follow MCK and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.